Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel.

Source:http://linkedlifedata.com/resource/pubmed/id/19282468

Download in:

View as

General Info

PMID
19282468